Anna Amela Valsecchi

43 posts

Anna Amela Valsecchi

@AAValsecchi

MD, PhD @unito 🌺 Ospedale Molinette, Torino

Torino, Piemonte شامل ہوئے Mayıs 2022

110 فالونگ91 فالوورز

Anna Amela Valsecchi ری ٹویٹ کیا

Tumori Journal@TumoriJ·9 Mar

💥Recognising #FinantialToxicity as a prognostic factor and integrating targeted support services, educational strategies and systemic reforms could substantially improve patient outcomes, #QoL, treatment adherence and equity in #CancerCare delivery. Learn more at the link 🔓journals.sagepub.com/share/NM3GGVSW… @MassimoDiMaio75 @fperrone62 @AAValsecchi

English

125

Anna Amela Valsecchi@AAValsecchi·25 Şub

👇🏻

Massimo Di Maio@MassimoDiMaio75

Have a look at this publication in @TumoriJ by @AAValsecchi Pamela Festa Maria Laura Malgarini: Patient-reported financial toxicity within Italian public healthcare system: A cross-sectional analysis in patients with cancer journals.sagepub.com/doi/full/10.11… (1/5)

ART

Anna Amela Valsecchi@AAValsecchi·22 Kas

🩷 #Breast cancer campus, Firenze

English

Anna Amela Valsecchi ری ٹویٹ کیا

Meet-URO@meeturoIT·9 Kas

Meeturo Young at #Aiom2025 @AAValsecchi @Simorota6 @dici_mattia

English

183

Anna Amela Valsecchi ری ٹویٹ کیا

Massimo Di Maio@MassimoDiMaio75·20 Eki

Even within the same country (Italy), use of off-label cancer drugs is subject to significant inter-hospital variability. This leads to potential disparities in patients' access to care. Have a look at the project by @AIOMtweet, just published on @TumoriJ: journals.sagepub.com/eprint/VXIKKBV…

English

952

Anna Amela Valsecchi ری ٹویٹ کیا

Meet-URO@meeturoIT·10 Eki

Bone Health and Body Composition as Predictive and Prognostic Markers in Metastatic Castration-resistant Prostate Cancer: A Meet-URO Narrative Review. Doi: doi.org/10.1016/j.clgc… @AAValsecchi #meeturo #clinicalgenitourinarycancer

English

312

Anna Amela Valsecchi@AAValsecchi·4 Eki

Bellissimo congresso! Ringrazio #AIOM per l’invito a parlare di “Oncologia, Industria e #Comunicazione: quando la scienza arriva nei titoli stampa” 📌

Italiano

Anna Amela Valsecchi@AAValsecchi·2 Eki

Talking about “Managing Toxicities Associated with #Sacituzumab Govitecan in mTNBC and HR+ MBC, with a Focus on Diarrhea and Neutropenia” w/ @VuMedi 👉🏼 vumedi.com/video/managing…

English

109

Anna Amela Valsecchi@AAValsecchi·27 Ağu

Out our latest review 👉🏼 mdpi.com/2072-6694/17/1…

English

Anna Amela Valsecchi@AAValsecchi·11 Haz

#BREAST IMPROVEMENT NETWORK - Carcinoma mammario avanzato, dalla terapia target alla terapia #tailored 💖 Torino, 11/6/25 e 15/10/2025

Italiano

Anna Amela Valsecchi ری ٹویٹ کیا

Massimo Di Maio@MassimoDiMaio75·2 Haz

Standing ovation for this trial at #ASCO25 . Practice changing. The problem could be the adherence to physical exercise. Accrual in the trial was very slow, because many patients refused randomization to exercise, I suppose. Education is crucial.

NEJM@NEJM

Presented at #ASCO25: A 3-year structured exercise program after adjuvant chemotherapy for colon cancer improved disease-free and overall survival, physical functioning, and fitness, as compared with health education alone. Full CHALLENGE phase 3 trial results: nej.md/4mh5RPL @ASCO

English

Anna Amela Valsecchi ری ٹویٹ کیا

Massimo Di Maio@MassimoDiMaio75·16 May

Check out our open access review on the association between #QoL measures and survival endpoints in #cancer clinical trials and in clinical decision making. Kudos to @AAValsecchi link.springer.com/article/10.100…

English

1.3K

Anna Amela Valsecchi@AAValsecchi·15 May

🩵

Meet-URO@meeturoIT

Consegnati i Meet-URO Awards 2025: Roberto Sabatini premiato per il contributo alla ricerca nei tumori genitourinari, Maria Concetta Cursano e Anna Amela Valsecchi vincono il Meet-URO YOUNG Award per il miglior progetto 2024. @g_procopio_ @IstTumori @UgoDeGiorgi @oncodaily

ART

Anna Amela Valsecchi@AAValsecchi·15 May

Delphy consensus on the management of #AEs in patients with #mTNBC treated with #sacituzumab govitecan 🎀 academic.oup.com/oncolo/article…

English

484

Anna Amela Valsecchi@AAValsecchi·23 Nis

Finally published our latest work: Press releases of industry-sponsored clinical trials in #oncology: Characteristics, timing and financial impact 📄 sciencedirect.com/science/articl… @MassimoDiMaio75

English

369

Anna Amela Valsecchi@AAValsecchi·6 Mar

Look at our latest publication about #breastcancer studies 💕 sciencedirect.com/science/articl… Thanks to @gaia_giannone and @Pasquale for involving me, and to all coauthors!

English

147

Anna Amela Valsecchi ری ٹویٹ کیا

Giuseppe Banna@gbanna74·10 Şub

Grateful to the oncology residents at @unito for the warm welcome during their Didactic Week, fantastic initiative by Silvia Novello to learn, network & grow together. Thanks to @LulieZumstein, @AAValsecchi & @O_Cantale for the flawless organization! Loved their curiosity!

English

641

Anna Amela Valsecchi ری ٹویٹ کیا

Lucrezia Zumstein@L__Zumstein·10 Kas

Out abstract at AIOM 2024 🧬 @AiomFondazione

English

116

Anna Amela Valsecchi@AAValsecchi·2 Eki

Have a look at our #PRO4All project just out, aiming to develop a #breast cancer specific comprehensive archive of #PROMs promoting a patient-centered approach 📌 @MassimoDiMaio75 @OrianaCiani @OncoAlert sciencedirect.com/science/articl…

English

1.4K

Anna Amela Valsecchi@AAValsecchi·31 Tem

🎀

Accademia Medicina@ACCMEDorg

KEY SLIDES | keyslides.it Datopotamab deruxtecan: le evidenze cliniche aggiornate A cura di @MassimoDiMaio75, Daniele Ierace, @AAValsecchi (TO) 48 diapositive commentate, PPT e PDF keyslides.accmed.org/miscellanea/it… #oncologia #oncology #breastcancer #lungcancer #ADC

ART

189

دریافت کریں

@MassimoDiMaio75 @fperrone62 @Simorota6 @dici_mattia @AIOMtweet @TumoriJ @VuMedi @gaia_giannone